IndianaIndiana law limits INSPECT reporting and allows guarded data sharing
Since July 1, 2026, Indiana law has excused some drug reports, required consent for opioid treatment program reports, and allowed limited sharing of monitoring data.
What it does
Dispensers do not have to report a drug given directly to a patient or a veterinarian’s supply of certain controlled drugs lasting no more than 72 hours.
Before reporting patient information to INSPECT, an opioid treatment program must get the patient’s consent under federal rules.
The board may share prescription monitoring data with certain state agency representatives to help with an active controlled substance investigation or prevent overdoses.
Argument forState health agencies could use monitoring data to help investigate controlled substances and prevent overdoses.
Argument againstPatients’ prescription records may be less complete when dispensers do not have to report directly given drugs or certain short veterinary supplies.
More detail
Dispensers do not have to send certain drug information to INSPECT. This applies to information dispensers otherwise must report under the INSPECT rules. The exception covers a drug given directly to a patient or a veterinary practitioner’s supply of no more than 72 hours of a Schedule II, III, IV, or V controlled drug. These provisions took effect July 1, 2026.
Opioid treatment programs must get patient consent before reporting patient information to INSPECT. The requirement applies when an opioid treatment program reports patient information to INSPECT. Programs must follow the consent rules in federal regulations 42 CFR 2.36 and 42 CFR 2.31. This provision took effect July 1, 2026.
The board may share prescription monitoring data with certain state agency representatives. The recipients may be representatives of the Indiana Department of Health or the office of the secretary of family and social services. The data may be shared to aid an active investigation concerning a controlled substance or help prevent overdose events. This provision took effect July 1, 2026.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Mar 5Public Law 133Latest
- Mar 5Signed by the Governor Mike BraunBecame Law
- Feb 27Signed by the SpeakerMajor
- Feb 27Signed by the President Pro TemporeMajor
- Feb 27Signed by the President of the SenateMajor
- Feb 25Senate concurred with House amendments; Roll Call 287: yeas 47, nays 0
- Vote recorded SB 262 - Crider. Result: pass.Upper
- Feb 24Returned to the Senate with amendmentsMinor
- Feb 24Motion to concur filedMinor
- Feb 23Third reading: passed; Roll Call 312: yeas 94, nays 0Passed House
- Vote recorded SB 262 - Goss-Reaves - 3rd Reading. Result: pass.Lower
- Feb 19Second reading: ordered engrossedMinor
- Feb 17Committee report: amend do pass, adoptedMinor
- Feb 2First reading: referred to Committee on Public HealthMinor
- Jan 29Referred to the HouseMinor
- Jan 28House sponsor: Representative Goss-Reaves
- Vote recorded SB 262 - Crider - 3rd Reading. Result: pass.Upper
- Jan 28Third reading: passed; Roll Call 127: yeas 48, nays 0Passed Senate
- Jan 28Cosponsors: Representatives Barrett, Ledbetter
- Jan 26Second reading: amended, ordered engrossedMinor
- Jan 26Amendment #2 (Crider) prevailed; voice voteMajor
- Jan 22Senator Charbonneau added as second author
- Jan 15Committee report: amend do pass, adoptedMinor
- Jan 8Authored by Senator Crider
- Jan 8First reading: referred to Committee on Health and Provider ServicesIntroduced
Healthcare